Markets Gone Wild

Thermo Fisher Scientific Exceeds Quarterly Earnings Expectations Quarterly Earnings Report Highlights Thermo Fisher Scientific (TMO) recently released their quarterly earnings report, revealing earnings of $6.10 per share. This surpassed the Zacks Consensus Estimate of $5.93 per share, showcasing the company’s strong performance in the market. In comparison to the previous year, Thermo Fisher’s earnings have…

Bronstein, Gewirtz & Grossman, LLC Investigating Potential Claims on XPLR Infrastructure, LP New York, NY / ACCESS Newswire / February 7, 2025 Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of XPLR Infrastructure, LP (“XPLR” or “the Company”) (NYSE:NEP). Investors who purchased XPLR securities are encouraged to obtain additional information…

Revolutionizing Insurance Procurement: AAFMAA’s Collaboration with Sapiens AAFMAA (Armed Forces Financial Network Association), an organization dedicated to serving the financial needs of military members and their families, recently announced its partnership with Sapiens International Corporation, a leading global provider of software solutions for the insurance industry. This collaboration aims to streamline the insurance procurement process…

Poseida Therapeutics Hosts Exciting Cell Therapy R&D Day, Showcasing Innovative Clinical and Preclinical Pipeline Emerging Leadership in Allogeneic CAR-T for Hematologic Malignancies Recently, Poseida Therapeutics, a clinical-stage allogeneic cell therapy and genetic medicines company, demonstrated its emerging leadership in allogeneic CAR-T for hematologic malignancies. This was showcased by the Phase 1 data of P-BCMA-ALLO1 and…